Werewolf Therapeutics (HOWL) Amortization of Deferred Charges (2020 - 2026)

Werewolf Therapeutics has reported Amortization of Deferred Charges for 7 years, with the latest figure at $176000.0 in Q2 2026.

• Amortization of Deferred Charges for Q2 2026 came in at $176000.0, down 66.15% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.9 million (up 5.02% YoY), and the FY2025 annual result was $2.1 million, up 59.54% from the prior year.
• Amortization of Deferred Charges fell to $176000.0 in Q2 2026, from $595000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $595000.0 in Q1 2026 and troughed at $141000.0 in Q4 2022.
• A 5-year average of $401944.4 and a median of $379500.0 in 2022 frame the typical range for Amortization of Deferred Charges.
• The widest annual swing landed in 2022, when Amortization of Deferred Charges surged 1181.82%; it then plunged 66.15% in 2026.
• A 5-year view of Amortization of Deferred Charges shows it stood at $141000.0 in 2022, then jumped by 157.45% to $363000.0 in 2023, then soared by 31.68% to $478000.0 in 2024, then increased by 21.34% to $580000.0 in 2025, then tumbled by 69.66% to $176000.0 in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $176000.0 in Q2 2026, $595000.0 in Q1 2026, and $580000.0 in Q4 2025.